Accenture reported strong fiscal Q4 2026 results, exceeding analyst estimates for both earnings and revenue. The company also issued a fiscal 2027 revenue outlook that surpassed Wall Street expectations, leading several analysts to raise their price targets.
Accenture's Q4 2026 performance significantly beat analyst expectations, with both EPS and revenue coming in higher than anticipated. This strong quarter was further bolstered by an optimistic fiscal 2027 revenue outlook, which also exceeded Wall Street's consensus. The positive results and forward guidance led to several analysts, including Morgan Stanley, Susquehanna, and Argus Research, increasing their price targets for ACN. While the stock saw a slight dip in pre-market trading, the overall sentiment from the filing is positive, indicating potential long-term growth and investor confidence. The key opportunity for traders lies in the potential for ACN to continue its upward trajectory given the strong financial health and positive analyst revisions, though short-term market reactions can be volatile.